Regulatory Update

Guide to Requirements for Transfer of Rights - COFEPRIS

COFEPRIS regulates the transfer of rights to ensure legal and technical compliance for medicines, medical devices, and biological products. Requirements include an application format, proof of payment, legal documentation, and a notice of operation. Transfers must be transparent, with continuous monitoring. Modifications now resolve within 24 hours instead of 3 months.

Published on:
July 19, 2024

The transfer of rights in the regulatory context is essential to ensure continuity and legality in the management of rights and obligations related to regulated products, such as medicines, medical devices and biological products, among others.

 

COFEPRIS regulates this process with the objective of guaranteeing that any transfer of rights is carried out in a transparent manner, ensuring that the new owners comply with the legal and technical requirements necessary for the proper operation and marketing of products under their responsibility. This includes evaluation of relevant documentation,verification of the transferee's suitability, and ongoing monitoring to ensure compliance with applicable regulations.

 

The requirements for the transfer of rights to medical devices are:

1. Application format

2. Proof of payment of rights

3. Accreditation of legal personality

4. Tag projects

5. Instructions/user manual project

6. Number or copy of the last registration document

7. Legal instrument that certifies the transfer

8. Letter of Representation

9. Notice of operation

10. Notify the transfer within 30 business days

 

Apart from the indicated requirements, the following must be considered:

• Application entered by assignee.

• Registration must be current.

• It should not be linked to any other procedure entered into the commission (technical/administrative modification, extension among others).

• Changes checked will be in accordance with the latest resolution.

• The Health Registry must be current. In case of presenting proof of Extension, the holder of the same must coincide with the transfer or in accordance with article 190 bis 5 of the RIS.

• Download, fill out and physically present the“Modification to the Conditions of the Health Registry” form, which must describe the conditions requested according to the modification (Says/Should say). Attach a letter with information that describes in detail the request signed by the legal representative.

• Download, fill out and present the “Medical Device Health Registry Project” format in editable digital format.

• Changes may be made in the “importer and distributor” category as long as they are reflected in your new label project. In which case, in addition to the rights transfer contract, they must present the letter(s) of representation that cover the actors in the supply chain and/or, where appropriate, a certified copy of the Letter of Representation or clarification in which A distributor has the power to appoint others as distributors. (In this case, 75% of the fee corresponding to the LFD registration will be paid).

• All information regarding the procedure must be presented in printed form.

 

The steps to follow to submit the procedures for immediate resolution modifications are:

1. Request an appointment at the Comprehensive Services Center (CIS) through the Appointment Request System to carry out COFEPRIS procedures.

2. Present the requirements indicated in the COFEPRIS Procedures and Services Agreement, in physical format.

3. After entering the procedure, the user will receive a security paper document within a maximum period of 24 hours, without the need to schedule an appointment for collection.

 

This guide was published on June 25th 2024and it starts operation until July 8, 2024, according to COFEPRIS web page.

Subscribe to newsletter
Subscribe to receive the latest blog posts to your inbox every week.
By subscribing, you agree to our Terms and Conditions.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.
Read more

Latest News

Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.

Regulatory Update
October 23, 2024

This week in medical device regulatory news: updated guidance on MDR requirements for legacy devices, China released new product guidelines, revised UK guidance on Conditional Marketing Authorizations, and more.

Regulatory Update
October 14, 2024

This week in medical device regulatory news: Brazil expedites registration of IVDs for mosquito-born diseases; new US FDA guidance on endosseous dental implants and abutments.

Regulatory Update
October 9, 2024

Our first round-up of October 2024 medical device regulatory updates includes new CLSI guidelines and an upcoming webinar in the US, new MDCG guidance documents in Europe, and new industry standards from the NMPA in China.

Regulatory Update
October 1, 2024

End of September 2024 brought updates from major markets: EU IVDR transition guidance for Class D IVDs, biocompatibility guidance from the US FDA, IVD family grouping regulations from Brazil, and more.

Contact us
Request information

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Our closest representative will get back to you within 24 hours.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Latest Blog Content

Explore our collection of articles, success stories, and regulatory updates, designed to help you take your product global.

Blog Article
Language Challenges in MedTech Going Global and Our Solution

Multilingual documentation presents ongoing compliance and logistical hurdles for MedTech manufacturers. Transla.Ai is an industry-specific translation tool that can accelerate and streamline the translation process.

Medical device supply chain
Blog Article
Managing your medical device supply chain

The connection between supplier controls and business risks is becoming increasingly evident. In this article, we discuss perspectives on how to maintain a compliant medical device supply chain.

Blog Article
Brazil: Adapting to Evolving Regulatory Markets

Brazil aligns medical device regulations with global standards, including Europe and the US. Recent updates and international compatibility attract manufacturers.

Blog Article
AI in Medtech Brazil

AI is revolutionizing MedTech in Brazil, enhancing healthcare through process optimization and data-driven decisions. Pure Global ensures swift, compliant market introduction of innovative solutions.